Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma

NCT00476073 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma Bronchiale

Interventions

DRUG: FLUTIFORM® (Formoterol fumarate / Fluticasone propionate)

Sponsor

Mundipharma Research Limited